Reagents and instruments for immunology, cell biology and molecular biology.

Log in



Forgot your password? Open account

0

0

Catalog
Research areas
Custom services
CRO services
Technical resources
Special offer
Contact

Reagents and instruments for immunology, cell biology and molecular biology.

Biorbyt

Biotrend USA > Biorbyt > Research > Molecular Biology > Nucleic acids extraction > RNA > Specie-specific > viral RNA

Extraction and purification of viral RNA

Extraction and purification of viral RNA

Spin-column

Spin-column

Search result : 13 product found

Refine your search :

RUOCE / IVD

Unconjugated 6

virus 3

Biochemicals 5
Inhibitor/Antagonist/Agonist 3
Protein/peptide 3
kit 2

virus 2

SDS-PAGE 2

APPLY FILTERS
REINITIALIZE

Cat#

Description

Cond.

Price Bef. VAT

orb782898-200

Viral RNAclean Kit

200t

orb782898-50

Viral RNAclean Kit

50Test

orb419354-1mg

Viral RNA-directed RNA polymerase L protein

1mg

orb419354-100ug

Viral RNA-directed RNA polymerase L protein

100ug

orb419354-20ug

Viral RNA-directed RNA polymerase L protein

20ug

orb1910432-1g

R6 is a new ionizable lipid driven from AI-Guided Ionizable Lipid Engineering (AGILE) platform for mRNA delivery. R6 LNPs exhibits a 5-fold increase in transfection potency in RAW 264.7 and shows its potential to be utilized for the development of non-viral mRNA delivery vectors for immune cells.

1g

orb1910432-250mg

R6 is a new ionizable lipid driven from AI-Guided Ionizable Lipid Engineering (AGILE) platform for mRNA delivery. R6 LNPs exhibits a 5-fold increase in transfection potency in RAW 264.7 and shows its potential to be utilized for the development of non-viral mRNA delivery vectors for immune cells.

250mg

orb1910432-100mg

R6 is a new ionizable lipid driven from AI-Guided Ionizable Lipid Engineering (AGILE) platform for mRNA delivery. R6 LNPs exhibits a 5-fold increase in transfection potency in RAW 264.7 and shows its potential to be utilized for the development of non-viral mRNA delivery vectors for immune cells.

100mg

orb1910409-1g

CU-CPD107 is a TLR8-specific small molecule with unique synergistic agonist activities in the presence of ssRNA, but inactive without the aid of ssRNA.CU-CPD107 significantly inhibited of R848-induced signaling in HEK-Blue hTLR8 cells with an IC50 of 13.7 uM.CU-CPD107 only inhibited synthesized small-molecule agonist-induced TLR8 signaling without affecting other TLRs.CU-CPD107 synergistically increased IFN-β, TNF-α, IL-1β, IL-6, and IL-8 mRNA expression levels in the presence of 5 μg/ml ssRNA40 in HEK-Blue hTLR8 cells, whereas CU-CPD107 alone did not. CU-CPD107 only activated TLR8-mediated signaling in the presence of ssRNA.CU-CPD107 showed no pure agonistic activity, addressing a major challenge that has existed for previous TLR7 and TLR8 agonists as vaccine adjuvants or antiviral drugs. [[2573912-32-8]]

1g

orb1910409-100mg

CU-CPD107 is a TLR8-specific small molecule with unique synergistic agonist activities in the presence of ssRNA, but inactive without the aid of ssRNA.CU-CPD107 significantly inhibited of R848-induced signaling in HEK-Blue hTLR8 cells with an IC50 of 13.7 uM.CU-CPD107 only inhibited synthesized small-molecule agonist-induced TLR8 signaling without affecting other TLRs.CU-CPD107 synergistically increased IFN-β, TNF-α, IL-1β, IL-6, and IL-8 mRNA expression levels in the presence of 5 μg/ml ssRNA40 in HEK-Blue hTLR8 cells, whereas CU-CPD107 alone did not. CU-CPD107 only activated TLR8-mediated signaling in the presence of ssRNA.CU-CPD107 showed no pure agonistic activity, addressing a major challenge that has existed for previous TLR7 and TLR8 agonists as vaccine adjuvants or antiviral drugs. [[2573912-32-8]]

100mg

orb1910409-250mg

CU-CPD107 is a TLR8-specific small molecule with unique synergistic agonist activities in the presence of ssRNA, but inactive without the aid of ssRNA.CU-CPD107 significantly inhibited of R848-induced signaling in HEK-Blue hTLR8 cells with an IC50 of 13.7 uM.CU-CPD107 only inhibited synthesized small-molecule agonist-induced TLR8 signaling without affecting other TLRs.CU-CPD107 synergistically increased IFN-β, TNF-α, IL-1β, IL-6, and IL-8 mRNA expression levels in the presence of 5 μg/ml ssRNA40 in HEK-Blue hTLR8 cells, whereas CU-CPD107 alone did not. CU-CPD107 only activated TLR8-mediated signaling in the presence of ssRNA.CU-CPD107 showed no pure agonistic activity, addressing a major challenge that has existed for previous TLR7 and TLR8 agonists as vaccine adjuvants or antiviral drugs. [[2573912-32-8]]

250mg

orb611624-1ml

ABX464 (ABX-464;ABX 464)

10mM*1mLinDMSO

orb1910919-10mg

GPS491

10mg

‹

›

c/o Carr Riggs Ingram,
500 Grand Boulevard, Suite 210
Miramar Beach, FL 32550 - USA
Tel.: +1 850 650 7790
Fax: +1 850 650 4383
Email: info@biotrend-usa.com

>> Worldwide offices and Distributors >>

Other information

Terms and conditions

Quality policies

All trademarks or registered trademarks appearing on this website are the property of their respective owners